Nov. 24 at 6:11 PM
$SLS Does Everyone REALIZE the BEST AVAILABLE TREATMENT for the REGAL P3 Control ARM is VEN+AZA?
--- VIALE-M was A Direct Existential Threat to GPS.
- and it FAILED.
Viale-M was a Phase 3 trial, Aza+VEN for AML Maintenance Trial for First Remission Patients (CR1) who were ineligible for Transplant.
The SLS REGAL Phase 3 Trial is also for AML Maintenance, in Second Remission Patients (CR2) who were ineligible for Transplant.
The original VIALE-M PRIMARY END POINT was RELAPSE FREE SURVIVAL and OS as a Secondary Outcome - at some point
$ABBV $BMY Modified the trial attempting to find a SAFE DOSING Regime -and were Unable, and terminated the trial.
RESULTS are Posted on NCT: Terminated / enrollment discontinued https://clinicaltrials.gov/study/NCT04102020?term=viale-m&rank=9&tab=history&a=26&b=27#version-content-panel
